Spielman J - Search Results

1

Bcl-2 protects against Fas-based but not perforin-based T cell-mediated cytolysis.

Lee RK, Spielman J, Podack ER. Lee RK, et al. Among authors: spielman j. Int Immunol. 1996 Jul;8(7):991-1000. doi: 10.1093/intimm/8.7.991. Int Immunol. 1996. PMID: 8757944

2

Consequences of Fas-ligand and perforin expression by colon T cells in a mouse model of inflammatory bowel disease.

Simpson SJ, De Jong YP, Shah SA, Comiskey M, Wang B, Spielman JA, Podack ER, Mizoguchi E, Bhan AK, Terhorst C. Simpson SJ, et al. Among authors: spielman ja. Gastroenterology. 1998 Oct;115(4):849-55. doi: 10.1016/s0016-5085(98)70256-2. Gastroenterology. 1998. PMID: 9753487

3

Perforin, Fas ligand, and tumor necrosis factor are the major cytotoxic molecules used by lymphokine-activated killer cells.

Lee RK, Spielman J, Zhao DY, Olsen KJ, Podack ER. Lee RK, et al. Among authors: spielman j. J Immunol. 1996 Sep 1;157(5):1919-25. J Immunol. 1996. PMID: 8757310

4

CD80 (B7.1) and CD54 (intracellular adhesion molecule-1) induce target cell susceptibility to promiscuous cytotoxic T cell lysis.

Nishio M, Spielman J, Lee RK, Nelson DL, Podack ER. Nishio M, et al. Among authors: spielman j. J Immunol. 1996 Nov 15;157(10):4347-53. J Immunol. 1996. PMID: 8906809

5

Perforin/Fas-ligand double deficiency is associated with macrophage expansion and severe pancreatitis.

Spielman J, Lee RK, Podack ER. Spielman J, et al. J Immunol. 1998 Dec 15;161(12):7063-70. J Immunol. 1998. PMID: 9862744

6

Abrogation of graft-versus-host disease following allotransplantation of cytotoxically deficient bone marrow across major histocompatibility barriers.

Selvaggi G, Inverardi L, Levy RB, Brendel MD, Spielman J, Mintz DH, Podack ER, Ricordi C. Selvaggi G, et al. Among authors: spielman j. Ann N Y Acad Sci. 1995 Dec 29;770:339-44. doi: 10.1111/j.1749-6632.1995.tb31065.x. Ann N Y Acad Sci. 1995. PMID: 8597370 No abstract available.

7

Small cell lung carcinomas express shared and private tumor antigens presented by HLA-A1 or HLA-A2.

Yamazaki K, Spruill G, Rhoderick J, Spielman J, Savaraj N, Podack ER. Yamazaki K, et al. Among authors: spielman j. Cancer Res. 1999 Sep 15;59(18):4642-50. Cancer Res. 1999. PMID: 10493519

8

Biosynthesis of a tumor cell surface sialomucin. Maturation and effects of monensin.

Spielman J, Hull SR, Sheng ZQ, Kanterman R, Bright A, Carraway KL. Spielman J, et al. J Biol Chem. 1988 Jul 15;263(20):9621-9. J Biol Chem. 1988. PMID: 3384816 Free article.

9

Temporal aspects of O-glycosylation and cell surface expression of ascites sialoglycoprotein-1, the major cell surface sialomucin of 13762 mammary ascites tumor cells.

Spielman J, Rockley NL, Carraway KL. Spielman J, et al. J Biol Chem. 1987 Jan 5;262(1):269-75. J Biol Chem. 1987. PMID: 3098740 Free article.

10

Structural and functional aspects of tumor cell sialomucins.

Carraway KL, Spielman J. Carraway KL, et al. Among authors: spielman j. Mol Cell Biochem. 1986 Nov-Dec;72(1-2):109-20. doi: 10.1007/BF00230639. Mol Cell Biochem. 1986. PMID: 3821720

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

36 results

Search Page

Filters